Back to ACAD

Palo Alto Investors LP → ACAD

Palo Alto Investors LP ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
5
Latest value
$50.1M
Q3 2026
Peak value
$72.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$66.3M
Q1 2026$63.9M
Q2 2026$72.5M
Q2 2026$72.5M
Q3 2026$50.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$50.1M2.49M——
Q2 2026$72.5M2.86M——
Q2 2026$72.5M2.86M——
Q1 2026$63.9M2.87M——
Q4 2025$66.3M2.48M——

Other funds holding ACAD

Other Palo Alto Investors LP positions

INSM

INSMED INC

$85.2M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
AMSF

AMICUS THERAPEUTICS INC

$74.1M
ACHC

ACADIA PHARMACEUTICALS INC

$72.5M
PTCT

PTC THERAPEUTICS INC

$68.7M
INSM

INSMED INC

$67.9M